{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T20:40:09Z","timestamp":1778272809175,"version":"3.51.4"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2019,1,12]],"date-time":"2019-01-12T00:00:00Z","timestamp":1547251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"GlaxoSmithKline Biologicals SA"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>To estimate the health care resource utilization, costs, and impact on quality of life (QoL) of herpes zoster (HZ) and postherpetic neuralgia (PHN) in adults aged \u226550 years in Italy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was a prospective, observational, multicenter, community physician\u2013based surveillance study (NCT01772160) in Italy. Health-related QoL data were collected using the EuroQoL-5 Dimension (EQ-5D) and Zoster Brief Pain Inventory (ZBPI) questionnaires. Both questionnaires were assessed at days 0 (HZ rash onset), 15, 30, 60, and 90 for all patients, and monthly thereafter for patients who developed PHN. Resource utilization was recorded for 3 months post\u2013HZ onset and 9 months for PHN patients. Costs from both payer and societal perspectives were estimated and were composed of direct medical costs (general practitioner\/specialist visits, procedures, hospitalizations, medications), work loss by patient\/caregiver, and transport costs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 391 patients with HZ were included, of whom 40 developed PHN. The mean ZBPI worst pain score was 5.7 at day 0, reducing to 2.6 at day 30 and 0.7 by day 90. Patients with PHN had a mean worst pain score of 5.7 at day 90. We estimated an overall disutility associated with HZ of 0.134. The mean cost per HZ patient from a payer\/societal perspective was \u20ac153\/\u20ac298, respectively, and the mean cost per HZ patients who developed PHN was \u20ac176\/\u20ac426, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>HZ is associated with impaired QoL and substantial health care resource use, highlighting the need for preventive strategies. This could reduce the disease burden for the patient and health care system.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>ClinicalTrials.gov study registry<\/jats:title>\n                  <jats:p>NCT01772160.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofz007","type":"journal-article","created":{"date-parts":[[2019,1,12]],"date-time":"2019-01-12T13:18:07Z","timestamp":1547299087000},"source":"Crossref","is-referenced-by-count":25,"title":["The Economic Burden and Impact on Quality of Life of Herpes Zoster and Postherpetic Neuralgia in Individuals Aged 50 Years or Older in Italy"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7427-7326","authenticated-orcid":false,"given":"Sean","family":"Matthews","sequence":"first","affiliation":[{"name":"Value Evidence, GSK, Wavre, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3058-365X","authenticated-orcid":false,"given":"Antonio","family":"De Maria","sequence":"additional","affiliation":[{"name":"Investigator site, Puglia, Galatina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Passamonti","sequence":"additional","affiliation":[{"name":"Investigator site, Lombardia, Fagnano Olona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5128-861X","authenticated-orcid":false,"given":"Giovanni","family":"Ristori","sequence":"additional","affiliation":[{"name":"Investigator site, Lazio, Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1508-7930","authenticated-orcid":false,"given":"Idalba","family":"Loiacono","sequence":"additional","affiliation":[{"name":"Payers and Evidence Solutions, GSK, Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4069-3759","authenticated-orcid":false,"given":"Anna","family":"Puggina","sequence":"additional","affiliation":[{"name":"Payers and Evidence Solutions, GSK, Verona, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7423-0111","authenticated-orcid":false,"given":"Desmond","family":"Curran","sequence":"additional","affiliation":[{"name":"Value Evidence, GSK, Wavre, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,1,12]]},"reference":[{"key":"2020081003470540300_CIT0001","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1090-3801(99)90015-0","article-title":"The lifetime occurrence of herpes zoster and prevalence of post-herpetic neuralgia: a retrospective survey in an elderly population","volume":"3","author":"Bowsher","year":"1999","journal-title":"Eur J Pain"},{"key":"2020081003470540300_CIT0002","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1017\/S0950268801005921","article-title":"Epidemiology of varicella zoster virus infection in Canada and the United Kingdom","volume":"127","author":"Brisson","year":"2001","journal-title":"Epidemiol Infect"},{"key":"2020081003470540300_CIT0003","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1016\/S0264-410X(01)00044-5","article-title":"The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales","volume":"19","author":"Edmunds","year":"2001","journal-title":"Vaccine"},{"key":"2020081003470540300_CIT0004","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1056\/NEJMcp1302674","article-title":"Herpes zoster","volume":"369","author":"Cohen","year":"2013","journal-title":"N Engl J Med"},{"key":"2020081003470540300_CIT0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-014-0637-6","article-title":"Burden of herpes zoster-associated chronic pain in Italian patients aged 50 years and over (2009-2010): a GP-based prospective cohort study","volume":"14","author":"Bricout","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2020081003470540300_CIT0006","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1016\/j.vaccine.2007.07.049","article-title":"Epidemiology and costs of herpes zoster: background data to estimate the impact of vaccination","volume":"25","author":"Di Legami","year":"2007","journal-title":"Vaccine"},{"key":"2020081003470540300_CIT0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-10-230","article-title":"Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study","volume":"10","author":"Gialloreti","year":"2010","journal-title":"BMC Infect Dis"},{"key":"2020081003470540300_CIT0008","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4161\/hv.35859","article-title":"The burden of disease of herpes zoster in Tuscany","volume":"11","author":"Levi","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"2020081003470540300_CIT0009","article-title":"Cross-sectional study on hospitalizations related to herpes zoster in an Italian region, 2008\u20132016","author":"Cocchio","journal-title":"Aging Clin Exp Res"},{"key":"2020081003470540300_CIT0010","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jpain.2004.06.001","article-title":"Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the Brief Pain Inventory","volume":"5","author":"Coplan","year":"2004","journal-title":"J Pain"},{"key":"2020081003470540300_CIT0011","author":"EuroQol","year":"2016"},{"key":"2020081003470540300_CIT0012","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/07853890109002087","article-title":"EQ-5D: a measure of health status from the EuroQol Group","volume":"33","author":"Rabin","year":"2001","journal-title":"Ann Med"},{"key":"2020081003470540300_CIT0013","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jval.2013.04.008","article-title":"Italian population-based values of EQ-5D health states","volume":"16","author":"Scalone","year":"2013","journal-title":"Value Health"},{"key":"2020081003470540300_CIT0014","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1017\/S0266462316000337","article-title":"Cost-effectiveness analysis of herpes zoster vaccination in Italian elderly persons","volume":"32","author":"Coretti","year":"2016","journal-title":"Int J Technol Assess Health Care"},{"key":"2020081003470540300_CIT0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4161\/hv.36160","article-title":"Evaluation of the economic burden of herpes zoster (HZ) infection","volume":"11","author":"Panatto","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"2020081003470540300_CIT0016","first-page":"98","article-title":"La gestione clinica ed i costi dell\u2019Herpes Zoster in Italia","volume-title":"G Farmacoeconomia","author":"Arpinelli","year":"2000"},{"key":"2020081003470540300_CIT0017","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.vaccine.2005.09.026","article-title":"The burden of herpes zoster: a prospective population based study","volume":"24","author":"Scott","year":"2006","journal-title":"Vaccine"},{"key":"2020081003470540300_CIT0018","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s40801-017-0119-4","article-title":"Economic burden of herpes zoster and post-herpetic neuralgia in adults 60 years of age or older: results from a prospective, physician practice-based cohort study in Kushiro, Japan","volume":"4","author":"Nakamura","year":"2017","journal-title":"Drugs Real World Outcomes"},{"key":"2020081003470540300_CIT0019","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jinf.2018.02.001","article-title":"Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged \u226550 years: a prospective study","volume":"76","author":"Schmidt-Ott","year":"2018","journal-title":"J Infect"},{"key":"2020081003470540300_CIT0020","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1212\/WNL.0b013e3182a3516e","article-title":"The global epidemiology of herpes zoster","volume":"81","author":"Yawn","year":"2013","journal-title":"Neurology"},{"key":"2020081003470540300_CIT0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-13-170","article-title":"Similar herpes zoster incidence across Europe: results from a systematic literature review","volume":"13","author":"Pinchinat","year":"2013","journal-title":"BMC Infect Dis"},{"key":"2020081003470540300_CIT0022","author":"United Nations Population Division"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/6\/2\/ofz007\/33576637\/ofz007.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/6\/2\/ofz007\/33576637\/ofz007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T07:48:10Z","timestamp":1597045690000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofz007\/5288627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,12]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofz007","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2019,1,12]]},"article-number":"ofz007"}}